Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients

---

Copy For Citation

SARI A., Guven D., ARMAĞAN B., ERDEN A., KALYONCU U., KARADAĞ Ö., ...More

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, vol.23, no.8, pp.411-415, 2017 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 23 Issue: 8
• Publication Date: 2017
• Doi Number: 10.1097/rhu.0000000000000584
• Journal Name: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.411-415
• Keywords: interstitial lung disease, rituximab, systemic sclerosis, MYCOPHENOLATE-MOFETIL, EUSTAR DATABASE, TRIAL, CYCLOPHOSPHAMIDE, SAFETY, SKIN, TRANSPLANTATION, EFFICACY, DEATH
• Hacettepe University Affiliated: Yes

Abstract

Objectives The objective of this study was to report the experience with rituximab treatment in a case series of patients with long-standing systemic sclerosis-associated interstitial lung disease (SSc-ILD).